Tau Aggregation Assay Service
The in vitro tau aggregation assay can simulate the process of tau protein misfolding and aggregation in vivo, providing an important tool for studying the role of tau protein in disease. For further information regarding the products and services provided, project-specific consultation, and pricing, please submit an inquiry here.
Introduction
Tau protein is a microtubule-associated protein whose primary function is to stabilize microtubule structure in neurons, thereby supporting axonal growth and synaptic plasticity. However, under pathological conditions, tau protein misfolds and aggregates to form neurofibrillary tangles (NFTs), one of the core pathological features of Alzheimer's disease. (AD) Abnormal aggregation of tau protein is not only closely associated with neurodegenerative diseases, but can also induce aggregation of other tau protein molecules through the "seed" effect.
Tau Aggregation Assays at Creative Biolabs
- In Vitro Aggregation Assays
In vitro aggregation experiments are an important method for studying tau protein aggregation, including experiments using recombinant or synthetic tau proteins. These methods typically use fluorescent probes (such as thioflavin T or ThT) to monitor the aggregation process of tau protein in real time. By monitoring changes in ThT fluorescence intensity, the aggregation rate and kinetic properties of tau protein can be evaluated in real time.
Fig.1 A neuronal seed model of tau accumulation.2, 4
- Cell Models
Recent progress in the study of tau protein aggregation, based on cell models, is significant. Our human induced pluripotent stem cell (iPSC) platform can help you use iPSC-derived neuronal models to express fluorescently labeled tau protein through lentiviral transfection, and observe the aggregation process of tau protein in cells.
Fig.2 Modeling tau aggregation using human iPSC-derived neurons.3, 4
- High Throughput Screening
To screen small molecules capable of regulating tau protein aggregation, our researchers have developed a high-throughput screening platform. This platform typically integrates fluorescent probes, automated equipment, and image analysis algorithms to efficiently evaluate the effects of compounds on tau aggregation. Linear regression kinetic analysis is used to monitor the tau aggregation rate in real time and accurately quantify the early aggregation kinetic parameters.
Fig.3 High throughput screening platform.
Applications
- Drug Development: Screening small molecules/antibodies that inhibit abnormal tau aggregation and evaluating dual regulation of compounds on oligomer toxicity and microtubule stability.
- Diagnostic Marker Development: Development of detection kits based on tau oligomers/phosphorylation sites to aid in early screening and efficacy monitoring.
- Disease Mechanism Research: Analyze the transsynaptic transmission mechanism of tau and explore the molecular drivers of neurodegenerative diseases.
To discuss pricing and scheduling for your tau research, please contact us.
References
- Zheng, Huiting, et al. "The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges." International Journal of Molecular Sciences 25.9 (2024): 4969.
- Amorim, Ines S., et al. "A seeding-based neuronal model of tau aggregation for use in drug discovery." PLoS One 18.4 (2023): e0283941.
- Verheyen, An, et al. "Using human iPSC-derived neurons to model TAU aggregation." PloS one 10.12 (2015): e0146127.
- Distributed under Open Access license CC BY 4.0, without modification.
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Anti-TNFα BBB Shuttle Antibody (NRZP-1022-ZP4105) (Cat#: NRZP-1022-ZP4105)
- iNeuMab™ Anti-FGFR1 Antibody (NRP-0422-P1244) (Cat#: NRP-0422-P1244)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P2293) (Cat#: NRP-0422-P2293)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1684) (Cat#: NRP-0422-P1684)
- iNeuMab™ Anti-Alpha Synuclein Antibody (NRP-0422-P614) (Cat#: NRP-0422-P614)
- iNeuMab™ Anti-SEZ6 Antibody (NRP-0422-P515) (Cat#: NRP-0422-P515)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeu™ Human Sensory Neurons (Cat#: NCL-2103-P62)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- Human Retinal Epithelial Cell ARPE-19 (Cat#: NCL2110P069)
- Rat Retinal Muller Cell Line, Immortalized (Cat#: NCL-21P6-192)
- iNeu™ Human Schwann Cell (Cat#: NCL-2103-P63)
- Human Brain Vascular Adventitial Fibroblasts (Cat#: NCL-21P6-014)
- Rat Olfactory Ensheathing Cells (Cat#: NRZP-1122-ZP162)
- Mouse Glioma Cell Line GL261 (Cat#: NCL-2108P28)
- Human Brain Microvascular Endothelial Cells (Cat#: NCL-2103-P133)
- Human Blood Brain Barrier Model (Cat#: NCL-2103-P187)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)